Skip to main content
. 2015 Mar 23;10(3):e0122052. doi: 10.1371/journal.pone.0122052

Table 3. Predictors of Treatment failure of illness episode in children 2–35 months hospitalized with WHO defined Severe Pneumonia.

Variables Crude Odds Ratio* Adjusted Odds ratio* (number of observations per model)
Age in months 0.93 (0.90, 0.96) <0.001
Age categories Model 1 (590) Model 2 (455) Model 3 (454)
 • 2–6 months 1.00 1.00 1.00 1.00
 • 7–11 months 0.67 (0.44, 1.01) 0.058 0.61 (0.40, 0.94) 0.024 0.56 (0.34, 0.91) 0.019 0.55 (0.34, 0.90) 0.018
 • 12–23 months 0.37 (0.21, 0.64) <0.001 0.33 (0.19, 0.58) <0.001 0.27 (0.13, 0.55) <0.001 0.27 (0.13, 0.55) <0.001
 • 24–35months 0.22 (0.05, 0.99) 0.049 0.18 (0.04, 0.83) 0.028 0.31 (0.06, 1.54) 0.153 0.34 (0.07, 1.72) 0.194
Gender 0.83 (0.59,1.18) 0.296
Breastfed 0.67 (0.28,1.61) 0.370
Wasting (594) (< -2 Weight for height/length) 1.49 (1.02, 2.16) 0.038
Stunting (598) (< -2 Height/Length for age) 1.25 (0.69, 2.27) 0.457
Hypoxia (SpO2 < 90%) 1.91 (1.33, 2.74) <0.001 2.00 (1.36, 2.93) <0.001 1.80 (1.15, 2.80) 0.010 1.81 (1.16, 2.83) 0.009
Febrile (Axillary temperature > 38.5°C) 0.94 (0.59, 1.51) 0.808
Any danger sign 1.65 (1.18, 2.32) 0.004 1.44 (1.01, 2.07) 0.045
Radiographic pneumonia 2.22 (1.49, 3.31) < 0.001 2.09 (1.37, 3.19) 0.001 2.12 (1.39, 3.24) 0.001
C-Reactive Protein (CRP) > 40 mg/L 1.15 (0.79, 1.67) 0.472
Nasopharyngeal aspirate positive for virus
 • Respiratory syncytial virus (RSV) 1.47 (0.91, 2.38) 0.115
 • Influenza A 0.31, 1.84) 0.533
 • Influenza B 0.37, 2.76) 0.989
 • Parainfluenza type 1 (PIV 1) 0.18, 1.37) 0.178
 • Parainfluenza type 2 (PIV 2) 0.20, 7.44) 0.819
 • Parainfluenza type 3 (PIV 3) 0.12, 1.06) 0.063
 • Human metapneumovirus (hMPV) 2.34 (0.62, 8.81) 0.209
Supplemented with zinc 0.83 (0.60, 1.17) 0.291

*Odds ratios (95% CI) and P-value calculated using Logistic Regression. Odds ratios > 1 indicates increased odds of treatment failure.

Results of multiple regressions with P-value >0.05 not shown in the table with the exception of age analyzed as a categorical variable.

Model 1 (Clinical variables): Adjusted for gender, breastfed, wasting, febrile and treatment with zinc.

Model 2 (Clinical + Radiographic pneumonia): Adjusted for gender, breastfed, wasting, febrile, any danger sign and treatment with zinc.

Model 3 (All variables): Adjusted for gender, breastfed, wasting, febrile, any danger sign, CRP, nasopharyngeal aspirate positive for RSV, PIV 1, 2 and 3, influenza A and B, hMPV and treatment with zinc.